Draft:Omaida Velazquez
Submission declined on 24 January 2025 by RangersRus (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 23 January 2025 by Cinder painter (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. Declined by Cinder painter 35 days ago. | |
Comment: not meeting Wikipedia:Notability (academics) Cinder painter (talk) 08:53, 23 January 2025 (UTC)
Omaida Velazquez | |
|---|---|
| Born | |
| Occupation(s) | Vascular Surgeon Researcher |
| Academic background | |
| Education | University of Medicine and Dentistry of New Jersey (MD) Stevens Institute of Technology (BS) |
| Academic work | |
| Institutions | University of Miami |
Omaida Caridad Velazquez is a Cuban-American surgeon and researcher. In 2015, she became the first Latina woman to lead a major academic surgery department in the United States, at University of Miami (UM) Health System-Leonard M. Miller School of Medicine, a position she held until 2023.
She is recognized as a Distinguished Fellow of the Society for Vascular Surgery, and was inducted into the National Academy of Medicine in 2022.
Early life and education
[edit]Velazquez was born in Cuba. Her father worked as ambulance driver and her mother was a seamstress.[1][2] After 15 years of unsuccessfully applying for permission to leave Cuba, she and her family immigrated to the United States during the Mariel boatlift crisis.[3][4]
After high school in Union City, New Jersey, she earned a BS in Chemical Biology from the Stevens Institute of Technology. She completed undergraduate research on the chemotherapeutic effects of sodium cyanate.[5][6] She received a MD from the University of Medicine and Dentistry of New Jersey in 1991, where she was valedictorian of her class.[7] Velazquez completed her residency in general surgery and fellowship in vascular and endovascular surgery, both at the University of Pennsylvania. In 1997, she received the Jonathan E. Rhoads Research Award as a resident.[8]
Career and research
[edit]Velazquez began her academic career after residency at the University of Pennsylvania, where she co-authored works on topics including abdominal aortic aneurysm repair, angiogenesis, and vasculogenesis.[9][10][11]
In 2007, Velazquez became the Chief of the Vascular and Endovascular Division at the University of Miami (UM) Health System-Leonard M. Miller School of Medicine. She was inducted into the American Society for Clinical Investigators in 2009.[12] In 2015, she was promoted to chair of surgery, becoming the first Latina woman to lead a major academic surgery department in the United States.[13][14]
Her work with UM colleague Zhao-Jun Liu showed E-selectin to be an important factor in promoting angiogenesis and healing, as well as a potential target for gene therapy.[15][16] This research led to a patent and the creation of a biotechnology company, Ambulero, Inc., in 2019.[17] The company, supported by funding from the National Institutes of Health, has received orphan drug designation to advance its candidate for Buerger disease, a rare form of vasculitis that can lead to limb amputation.[18] Velazquez serves as Chief Medical Officer of Ambulero.[19]
In 2021, she was recognized as the Latina Pioneer of the Year at the 20th Annual Hispanic Women of Distinction Charity Awards Luncheon.[20]
Velazquez was inducted into the National Academy of Medicine in 2022.[21] She is also a Distinguished Fellow of the Society for Vascular Surgery.[22]
In 2023, she was dismissed from her position as chair of surgery.[23] Velazquez subsequently filed a lawsuit against UM through her attorneys, alleging discrimination and retaliation.[24][25][26] As of September 2024 the case is ongoing and she remains a tenured professor at UM.[27]
References
[edit]- ^ Angelini, Jill (1991-06-11). "From the nightmare of Mariel to medical school valedictorian". The Jersey Journal. p. 15.
- ^ Squadrito Moskovitz, Cheryl (2003-06-03). "For a vascular surgeon, life is literally in her hands". Courier-Post. p. 47. Retrieved 2025-02-20.
- ^ "Celebrating Hispanic History Month - A Profile on Omaida Caridad Velázquez, MD | Society for Vascular Surgery". vascular.org. Retrieved 2025-01-23.
- ^ "Omaida Velazquez, NAM". American Society of Science, Engineering, & Medicine of Florida. Retrieved 22 January 2025.
- ^ Avery, Henry G. (1986). "The UPTAM challenge". The Stevens Indicator. Stevens Institute of Technology. p. 13. Retrieved 2025-02-19.
- ^ "Biomedical program a hit". The Jersey Journal. 1985-07-25. p. 20. Retrieved 2025-02-20.
- ^ Shanahan, Edward K. (1991-06-22). "Cuban refugee top medical student". The Jersey Journal. p. 2. Retrieved 2025-02-20.
- ^ "Jonathan E. Rhoads Research Award". Penn Medicine. Retrieved 23 January 2025.
- ^ Carpenter, Jeffrey P.; Baum, Richard A.; Barker, Clyde F.; Golden, Michael A.; Mitchell, Mark E.; Velazquez, Omaida C.; Fairman, Ronald M. (2001-12-01). "Impact of exclusion criteria on patient selection for endovascular abdominal aortic aneurysm repair". Journal of Vascular Surgery. 34 (6): 1050–1054. doi:10.1067/mva.2001.120037. ISSN 0741-5214. PMID 11743559.
- ^ Velazquez, Omaida C.; Bavaria, Joseph E.; Pochettino, Alberto; Carpenter, Jeffrey P. (1999). "Emergency repair of thoracoabdominal aortic aneurysms with immediate presentation". Journal of Vascular Surgery. 30 (6): 996–1003. doi:10.1016/s0741-5214(99)70037-6. ISSN 0741-5214. PMID 10587383.
- ^ Bauer, Stephen M.; Bauer, Richard J.; Velazquez, Omaida C. (2005-07-01). "Angiogenesis, Vasculogenesis, and Induction of Healing in Chronic Wounds". Vascular and Endovascular Surgery. 39 (4): 293–306. doi:10.1177/153857440503900401. ISSN 1538-5744. PMID 16079938.
- ^ "Members elected in 2009". The American Society for Clinical Investigators. Retrieved 22 January 2025.
- ^ "UHealth's Dr. Velazquez Becomes First Latina in the U.S. To Become Chair of Department of Surgery". WSFL. 2021-09-27. Retrieved 2025-01-23.
- ^ "Spotlight on Leadership: Interview with Omaida Velazquez, MD | Society for Vascular Surgery". vascular.org. Retrieved 2025-01-23.
- ^ Quiroz, Hallie J.; Parikh, Punam P.; Lassance-Soares, Roberta M.; Regueiro, Manuela M.; Li, Yan; Shao, Hongwei; Vazquez-Padron, Roberto; Percival, Justin; Liu, Zhao-Jun; Velazquez, Omaida C. (2021). "Gangrene, revascularization, and limb function improved with E-selectin/adeno-associated virus gene therapy". JVS-Vascular Science. 2: 20–32. doi:10.1016/j.jvssci.2020.10.001. PMC 8489216. PMID 34617055.
- ^ Ribieras, Antoine J.; Ortiz, Yulexi Y.; Li, Yan; Le, Nga T.; Huerta, Carlos T.; Voza, Francesca A.; Shao, Hongwei; Vazquez-Padron, Roberto I.; Liu, Zhao-Jun; Velazquez, Omaida C. (2023). "E-Selectin/AAV Gene Therapy Promotes Myogenesis and Skeletal Muscle Recovery in a Mouse Hindlimb Ischemia Model". Cardiovascular Therapeutics. 2023: 1–10. doi:10.1155/2023/6679390. ISSN 1755-5922. PMC 10219778. PMID 37251271.
- ^ Huerta, Carlos Theodore; Ortiz, Yulexi Y.; Li, Yan; Ribieras, Antoine J.; Voza, Francesca; Le, Nga; Dodson, Caroline; Wang, Gaofeng; Vazquez-Padron, Roberto I.; Liu, Zhao-Jun; Velazquez, Omaida C. (2023-06-19). "Novel Gene-Modified Mesenchymal Stem Cell Therapy Reverses Impaired Wound Healing in Ischemic Limbs". Annals of Surgery. 278 (3): 383–395. doi:10.1097/SLA.0000000000005949. ISSN 0003-4932. PMC 10414148. PMID 37334717.
- ^ "Ambulero's Investigational Gene Therapy to Treat Vascular Disease Supported by NIH Funding". Endovascular Today. Retrieved 23 January 2025.
- ^ "Board and Advisors". Ambulero. Retrieved 2025-01-23.
- ^ Garcia, Joey (2021-09-14). "Dr. Omaida Velazquez Honored as Latina Pioneer of the Year". InventUM. Retrieved 2025-01-23.
- ^ Lewis, Talia (17 October 2022). "National Academy of Medicine Elects 100 New Members". National Academy of Medicine. Retrieved 22 January 2025.
- ^ "Celebrating Hispanic History Month - A Profile on Omaida Caridad Velázquez, MD | Society for Vascular Surgery". vascular.org. Retrieved 2025-02-20.
- ^ "Judge Says University of Miami Should Face Discrimination Case by Ex-Department Chair". Daily Business Review. Retrieved 2025-01-23.
- ^ Levy, Annelise (8 February 2023). "Univ. of Miami a 'Vipers' Nest' of Bias, Ex-Surgery Chair Says". Bloomberg Law. Retrieved 22 January 2025.
- ^ Marchante, Michelle (11 February 2023). "University of Miami's first Latina top surgeon sues, alleges whistle-blower retaliation". Miami Herald. Retrieved 22 January 2025.
- ^ "University of Miami's first Latina top surgeon sues, alleges whistle-blower retaliation". AOL. 2023-02-10. Retrieved 2025-01-23.
- ^ "Dr. Omaida C. Velazquez Wins Major Legal Battle In A Lawsuit Against University Of Miami Health System - Calle Ocho News". Calle Ocho news. 2024-09-09. Retrieved 2025-01-23.
- meet any of the eight academic-specific criteria
- or cite multiple reliable, secondary sources independent of the subject, which cover the subject in some depth
Make sure your draft meets one of the criteria above before resubmitting. Learn about mistakes to avoid when addressing this issue. If the subject does not meet any of the criteria, it is not suitable for Wikipedia.